In this week’s View, Dr. Eagle explores a study on the effect of low-dose aspirin vs. placebo on the development of anemia. He then discusses the PARAGLIDE-HF study on the use of ARNI agents in patients with mildly reduced or preserved ejection fraction and worsening heart failure. Finally, Dr. Eagle looks at the very important study on the value of bempedoic acid in primary prevention for patients who are statin-intolerant. 

Subscribe to Eagle’s Eye View